|
Sign In to gain access to subscriptions and/or personal tools.
|
Activation of protective and damaging components of the cardiac renin-angiotensin system after myocardial infarction in experimental diabetes
Tom Bäcklund
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Päivi Lakkisto
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Clinical Chemistry, Helsinki University Central Hospital, Helsinki, Finland
Eeva Palojoki
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Tina Grönholm
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Antti Saraste
Department of Anatomy, University of Turku, Turku, Finland
Piet Finckenberg
Institute of Biomedicine, Pharmacology, University of Helsinki, Biomedicum Helsinki, Finland
Eero Mervaala
Institute of Biomedicine, Pharmacology, University of Helsinki, Biomedicum Helsinki, Finland
Ilkka Tikkanen
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, ilkka.tikkanen{at}helsinki.fi, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland
Mika Laine
Minerva Foundation Institute for Medical Research, Biomedicum, Helsinki, Haartmaninkatu 8, FIN-00029 Helsinki, Finland, Department of Cardiology, Helsinki University Central Hospital, Helsinki, Finland
Introduction. Diabetes is associated with prolonged apoptotic cell death of cardiac myocytes and adverse remodelling after myocardial infarction (MI). Because the renin-angiotensin system (RAS) has a major role in the remodelling, we studied whether diabetes is associated with altered regulation of RAS after MI in rats.
Methods. Male Wistar rats were randomised to receive either streptozotocin (diabetic group) or citrate buffer (control group) intravenously. MI was produced four weeks later by ligating the left descending coronary artery.The rats were sacrificed 1, 4 and 12 weeks after the operation. Angiotensin-converting enzyme (ACE) and angiotensin-converting enzyme 2 (ACE 2), angiotensin type 1 and 2 receptors (AT1-receptor, AT2-receptor), and connective tissue growth factor (CTGF) mRNA expression were determined.
Results. The expression of both protective and damaging components of RAS increased after MI. However, myocardial ACE 2 and AT2-receptor messenger ribonucleic acid (mRNA) expression levels were significantly lower in diabetic compared to non-diabetic rats 1 week after MI. In contrast, AT1-receptor, ACE and CTGF mRNA levels were up-regulated in diabetic as compared with non-diabetic rats 12 weeks after MI.
Conclusion. The activation of the protective components of RAS (ACE 2 and AT2-receptor) was blunted early after MI in diabetic rats, whereas the levels of ACE, AT1-receptor and CTGF mRNA leading to adverse effects on myocardium, were elevated in diabetic as compared with non-diabetic rats.This unbalanced activation of the RAS may influence the pathophysiology of myocardial injury in diabetes after MI.
Key Words: renin-angiotensin system myocardial infarction diabetes
References
- Woodfield SL, Lundergan CF, Reiner JS et al. Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience. J Am Coll Cardiol 1996;28:1661-9.[Abstract]
- De Mello WC, Danser AH Angiotensin II and the heart: on the intracrine renin-angiotensin system. Review. Hypertension 2000;35:1183-8.
- Liu Y., Leri A., Li B. et al. Angiotensin II stimulation in vitro induces hypertrophy of normal and postinfarcted ventricular myocytes. Circ Res 1998;82:1145-59.[Abstract/Free Full Text]
- Backlund T., Palojoki E., Saraste A. et al. Sustained cardiomyocyte apoptosis and left ventricular remodeling after myocardial infarction in experimental diabetes. Diabetologia 2004;47:325-30.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Shiomi T., Tsutsui H., Ikeuchi M. et al. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 2003;42:65-72.
- Goussev A., Sharov VG, Shimoyama H. et al. Effects of ACE inhibition on cardiomyocyte apoptosis in dogs with heart failure. Am J Physiol 1998;275:H626-H631.[Web of Science][Medline]
[Order article via Infotrieve]
- Backlund T., Palojoki E., Saraste A. et al. Effects of vasopeptidase inhibitor omapatrilat on cardiomyocyte apoptosis and ventricular remodeling in rat myocardial infarction. Cardiovasc Res 2003;57:727-37.[Abstract/Free Full Text]
- Ozono R., Matsumoto T., Shingu T. et al. Expression and localization of angiotensin subtype receptor proteins in the hypertensive rat heart. Am J Physiol Regul Integr Comp Physiol 2000;278:R781-9.[Abstract/Free Full Text]
- Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Review. Circ Res 1998;83:1182-91.[Abstract/Free Full Text]
- Weber KT, Brilla CG Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Review. Circulation 1991;83:1849-65.
- Booz GW, Baker KM Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996;28:635-40.[Abstract/Free Full Text]
- Jin XQ, Fukuda N., Su JZ et al. Angiotensin II type 2 receptor gene transfer downregulates angiotensin II type 1a receptor in vascular smooth muscle cells. Hypertension 2002;39:1021-7.[Abstract/Free Full Text]
- Stoll M., Steckelings UM, Paul M. et al. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-7.[Web of Science][Medline]
[Order article via Infotrieve]
- Oishi Y., Ozono R., Yano Y. et al. Cardioprotective role of AT2-receptor in postinfarction left ventricular remodeling. Hypertension 2003;43:814-18.[Web of Science]
- Donoghue M., Hsieh F., Baronas E. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE 2) converts angiotensin I to angiotensin 1-9. Circ Res 2000;87:E1-E9.[Web of Science][Medline]
[Order article via Infotrieve]
- Burrell LM, Risvanis J., Kubota E. et al. Myocardial infarction increases ACE 2 expression in rat and humans. Eur Heart J 2005;26:369-75.[Abstract/Free Full Text]
- Palojoki E., Saraste A., Eriksson A. et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001;280:H2726-H2731. 18. Pfeffer MA, Pfeffer JM, Fishbein MC et al. Myocardial infarct size and ventricular function in rats. Circ Res 1979;44:508-12.
- Lakkisto P., Palojoki E., Backlund T. et al. Expression of heme oxygenase-1 in response to myocardial infarction in rats. J Mol Cell Cardiol 2002;34:1357-65.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Finckenberg P., Inkinen K., Ahonen J. et al. Angiotensin II induces connective tissue growth factor gene expression via calcineurin-dependent pathways. Am J Pathol 2003;163:355-66.[Abstract/Free Full Text]
- Saraste A., Pulkki K., Kallajoki M. et al. Apoptosis in human acute myocardial infarction. Circulation 1997;95:320-3.[Abstract/Free Full Text]
- Kohzuki M., Johnston CI, Chai SY et al. Measurement of angiotensin converting enzyme induction and inhibition using quantitative in vitro autoradiography: tissue selective induction after chronic lisinopril treatment. J Hypertens 1991;9:579-87.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zhuo J., Ohishi M., Mendelsohn FAO. Roles of AT1 and AT2-receptors in the hypertensive ren-2 gene transgenic rat kidney. Hypertension 1999;33:347-53.[Abstract/Free Full Text]
- Brown L., Wall D., Marchant C., Sernia C. Tissue-specific changes in angiotensin II receptors in streptozotocin-diabetic rats. J Endocrinol 1997;154:355-62.[Abstract/Free Full Text]
- Kajstura J., Cigola E., Malhotra A. et al. Angiotensin II induces apoptosis of adult ventricular myocytes in vitro. J Mol Cell Cardiol 1997;29:859-70.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Machackova J., Liu X., Lukas A. et al. Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes. Mol Cell Biochem 2004;261:271-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Zhu YC, Zhu YZ, Lu N. et al. Role of angiotensin AT1 and AT2-receptors in cardiac hypertrophy and cardiac remodeling. Clin Exp Pharm Physiol 2003;30:911-18.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Ferrario CM, Jessup J., Chappel MC et al. Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005;111:2605-10.[Abstract/Free Full Text]
- Cracower MA, Sarao R., Oudit GY et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002;417:822-8.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Adachi Y., SaitoY., Kishimoto I. et al. Angiotensin II type 2 receptor deficiency exacerbates heart failure and reduces survival after acute myocardial infarction in mice. Circulation 2003;107:2406-08.[Abstract/Free Full Text]
- Yang Z., Bove CM, French BA et al. Angiotensin II type 2 receptor overexpression preserves left ventricular function after myocardial infarction. Circulation 2002;106:106-11.[Abstract/Free Full Text]
- Nio Y., Matsubara H., Murasawa S. et al. Regulation of gene transcription of angiotensin II receptor subtypes in myocardial infarction. J Clin Invest 1995;95:46-54.[Web of Science][Medline]
[Order article via Infotrieve]
- Duncan MR, Frazier KS, Abramson S. et al. Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by camp. FASEB J 1999;13:1774-86.[Abstract/Free Full Text]
- Way KJ, Isshiki K., Suzuma K. et al. Expression of connective tissue growth factor is increased in injured myocardium associated with protein kinase C beta2 activation and diabetes. Diabetes 2002;51:2709-18.[Abstract/Free Full Text]
- Ruperez M., D Lorenzo O., Blanco-Colio LM et al. Connective tissue growth factor is a mediator of angiotensin II -induced fibrosis. Circulation 2003;108:1499-505. 36. Ohnishi H., Oka T., Kusachi S. et al. Increased expression of connective tissue growth factor in the infarct zone of experimentally induced myocardial infarction in rats. J Mol Cell Cardiol 1998;30:2411-22.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chen MM, Lam A., Abraham JA et al. CTGF expression is induced by TGF-b in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol 2000;32:1805-19.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
Journal of Renin-Angiotensin-Aldosterone System, Vol. 8, No. 2,
66-73 (2007)
DOI: 10.3317/jraas.2007.018

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
|
|